SCHEMBL10065288

SCHEMBL10065288

c1ccc(-c2cccc(-c3ccc4c(c3)c3ccccc3n4-c3ccc(-c4ccc(-c5nc6ccccc6o5)cc4)cc3)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 7/20 0.46
▸ RAB9A P51151 5/20 0.46
▸ KDM4E B2RXH2 6/20 0.45
▸ HPGD P15428 6/20 0.45
▸ SMN1; SMN2 Q16637 6/20 0.45
▸ ALDH1A1 P00352 5/20 0.45
▸ HSD17B10 Q99714 4/20 0.45
▸ TP53 P04637 2/20 0.45
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ ATM Q13315 1/20 0.45
▸ PKM P14618 1/20 0.44
▸ CASP3 P42574 3/20 0.42
▸ SENP7 Q9BQF6 3/20 0.42
▸ SENP6 Q9GZR1 3/20 0.42
▸ USP2 O75604 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ SENP8 Q96LD8 2/20 0.42
▸ HCRTR1 O43613 1/20 0.42
▸ TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10065179 1.00 NPC1 (0.46) NPC1RAB9AKDM4EHPGDSMN1; SMN2
SCHEMBL308089 0.98 NPC1 (0.48) NPC1RAB9AKDM4EHPGDSMN1; SMN2
SCHEMBL10065366 0.98 NPC1 (0.48) NPC1RAB9AKDM4EHPGDSMN1; SMN2
SCHEMBL10065294 0.98 NPC1 (0.48) NPC1RAB9AKDM4EHPGDSMN1; SMN2
SCHEMBL10065282 0.98 NPC1 (0.48) NPC1RAB9AKDM4EHPGDSMN1; SMN2
SCHEMBL10065178 0.98 NPC1 (0.48) NPC1RAB9AKDM4EHPGDSMN1; SMN2
SCHEMBL10065286 0.98 NPC1 (0.48) NPC1RAB9AKDM4EHPGDSMN1; SMN2
SCHEMBL10065374 0.98 NPC1 (0.48) NPC1RAB9AKDM4EHPGDSMN1; SMN2
SCHEMBL10065317 0.98 NPC1 (0.48) NPC1RAB9AKDM4EHPGDSMN1; SMN2
SCHEMBL10065297 0.98 NPC1 (0.48) NPC1RAB9AKDM4EHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735597-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-05-27 — — US disclosed
US-8735597-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-05-27 — — US disclosed
US-20120104376-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-05-03 — — US disclosed
US-20120104376-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-05-03 — — US disclosed
US-8093399-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-01-10 — — US disclosed
US-8093399-B2 Benzoxazole derivative, and light-emitting element, light-emitting device, and electronic device using benzoxazole derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-01-10 — — US disclosed
US-20100060154-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2010-03-11 — — US disclosed
US-20100060154-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2010-03-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100060154-A1 Benzoxazole Derivative, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Benzoxazole Derivative GABRA1, GABRA4, GABRA5 NPC1 4146/4885RAB9A 2525/4885KDM4E 3212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback